Covid-19 Track­er up­dates vac­cine can­di­dates

By Jeff Craven

On March 11, the World Health Or­ga­ni­za­tion clas­si­fied the Covid-19 out­break as a pan­dem­ic. The dis­ease has reached near­ly every coun­try, in­fect­ing hun­dreds of thou­sands of peo­ple and killing thou­sands.

Cur­rent­ly, there are no FDA-ap­proved ther­a­pies or vac­cines for SARS-CoV-2, the virus that caus­es Covid-19. The Na­tion­al In­sti­tute of Al­ler­gy and In­fec­tious Dis­eases (NI­AID) with­in the Na­tion­al In­sti­tutes of Health (NIH) is lead­ing the fund­ing of fed­er­al re­search and re­sponse to Covid-19, while some com­pa­nies in the US are choos­ing to fund their own Covid-19 re­search. In­ter­na­tion­al­ly, the UK Med­i­cines and Health­care prod­ucts Reg­u­la­to­ry Agency (MHRA) and Eu­ro­pean Med­i­cines Agency (EMA) have called for tar­get­ed ef­forts to de­vel­op ther­a­pies against Covid-19.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN